Showing results (251-260 of 768) with videos related to

Sort By:
Pageof 77
Thrombosis and Haemostasis|September 1, 1996
Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adultsJ O Johansson, K Landin, G Johannsson, et al.
Lupus|December 1, 1996
Factor V:Q506 mutation and anticardiolipin antibodies in systemic lupus erythematosusA Bengtsson, B Zöller, P G de Frutos, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1988
Continuous 24-hour secretion of growth hormone during late pregnancy. A regulator of maternal metabolic adjustment?L Eriksson, S Edén, N Fröhlander, et al.
The Journal of Rheumatology|April 1, 2000
Novel roles of complement in systemic lupus erythematosus--hypothesis for a pathogenetic vicious circleG Sturfelt, A Bengtsson, C Klint, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|September 1, 1992
Effects of growth hormone on fat mass and fat distributionB A Bengtsson, R J Brummer, S Edén, et al.
Arthritis Research & Therapy|December 5, 2013
Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosusJennie Bäck, Christian Lood, Anders A Bengtsson, et al.
The Annals of Thoracic Surgery|December 1, 1993
Hemofiltration modifies complement activation after extracorporeal circulation in infantsS Andreasson, S Göthberg, H Berggren, et al.
Annals of the Rheumatic Diseases|December 1, 1987
T cell subsets and expression of immunological activation markers in the arterial walls of patients with giant cell arteritisR Andersson, R Jonsson, A Tarkowski, et al.
Nature Reviews. Rheumatology|March 22, 2018
The non-haemostatic role of platelets in systemic lupus erythematosusPetrus Linge, Paul R Fortin, Christian Lood, et al.
Clinical Endocrinology|November 1, 1994
Serum lipoproteins in acromegaly before and 6-15 months after transsphenoidal adenomectomyJ Oscarsson, O Wiklund, K E Jakobsson, et al.
Pageof 77